Challenging heart rhythm disorders, or arrhythmias, require electrophysiology (EP)
technologies to pinpoint and ultimately fix problem areas within the heart’s electrical
circuitry during an interventional procedure. As EP procedure volume increases
worldwide, clinicians are requesting intuitive, advanced tools to help shorten procedure
times and gain detailed visualizations for interventions. Recognizing this, Royal Philips
Electronics (NYSE: PHG, AEX: PHI) today announced an agreement with Bard
Electrophysiology, a division of C. R. Bard, Inc., to co-develop new clinical tools that will
be designed to help electrophysiologists meet these needs and aid patients suffering
from arrhythmias.
Cardiac arrhythmia can lead to serious health risks, including heart failure or stroke.
Atrial fibrillation – a heart rhythm disorder characterized by irregular, rapid beating of the
atrial chambers – is found in about 2.2 million Americans and 4.5 million Europeans.
With robust EP technologies, clinicians may be better able to evaluate and diagnose
abnormalities in the heart’s electrical activity.
The goal of the combination of Bard’s LabSystemTM PRO EP Recording System and
Philips’ EP navigator and the Allura Xper FD series is to provide electrophysiologists a
faster and easier way to integrate image guidance with mapping and analysis of complex
arrhythmias, while offering insights for more accurate interventional navigation. EP
physicians and lab staff may also benefit from improved workflow in the EP lab due to
integration and compatibility between Philips and Bard technologies.
"Providing simpler and more intuitive approaches to the management of complex
arrhythmias is something that fascinates me. Significant advancement in science and
technology is frequently made when two seemingly dissimilar techniques are merged.
The collaboration between Bard Electrophysiology and Philips is very promising, and I
am looking forward to learning more about the potential for these new technologies in
my practice," commented Dr Michael V. Orlov, MD, PhD is the Director of Arrhythmia
Service at Caritas St. Elizabeth's Medical Center of Boston and an Associate Professor
of Medicine at Tufts University School of Medicine.
“Philips is dedicated to simplifying heart rhythm care. The relationship with Bard
exemplifies our strategy of collaborating with best-in-class companies to develop
solutions that address the needs of the electrophysiologists and their patients,” said
Gerard Winkels, vice president and general manager Electrophysiology for Philips
Healthcare. “The collaboration with Bard Electrophysiology will allow us to bring new
clinical tools to market aiming to enable our joint customers to perform EP procedures
faster and more simply and allow them to provide enhanced care offerings for their
patients.”
Dave Hemink, vice president and general manager, Bard Electrophysiology said, “This
alliance will provide us the opportunity to fundamentally impact the way that we analyze
and diagnose complex arrhythmias. We recognize that current solutions are complex
and time consuming. Together with Philips, we will innovate towards simpler approaches
to these clinical challenges, with a focus on helping healthcare providers’ EP labs
achieve greater business potential through expanded functionality and improved
efficiencies.”

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified
Health and Well-being company, focused on improving people’s lives through timely
innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates
technologies and design into people-centric solutions, based on fundamental customer
insights and the brand promise of “sense and simplicity”. Headquartered in the
Netherlands, Philips employs approximately 128,000 employees in more than 60
countries worldwide. With sales of $42 billion (EUR 27 billion) in 2007, the company is a
market leader in cardiac care, acute care and home healthcare, energy efficient lighting
solutions and new lighting applications, as well as lifestyle products for personal wellbeing
and pleasure with strong leadership positions in flat TV, male shaving and
grooming, portable entertainment and oral healthcare. News from Philips is located at
www.philips.com/newscenter.

About Bard Electrophysiology
Bard Electrophysiology, a division of C. R. Bard, Inc., is a global company focused on
the development and delivery of a broad range of devices for the diagnosis and
treatment of cardiac arrhythmias. We offer the electrophysiologist a product portfolio
including advanced RF ablation and mapping catheters, diagnostic catheters, EP
recording systems and stimulators, and intracardiac access products. Through our rich
history of commitment to innovative products, unparalleled support, and a dedication to
education worldwide, Bard Electrophysiology continues to be a leader in the field of EP.
For more information about Bard Electrophysiology, please visit us at www.bardep.com.

Bard is a registered trademark of C. R. Bard, Inc. or an affiliate. LabSystem is a trademark of C. R. Bard, Inc. or an affiliate. All other trademarks or registered
trademarks are the property of their respective owners. © 2009 C. R. Bard, Inc. All rights reserved. LT04Z0368/Rev.0/01-2009